IPS Biopharma AG is pioneering interventional immuno-oncology by transforming standard-of-care tumor ablations into a powerful immunotherapy against metastatic cancers. Our technology induces a tumor-specific immune response from thermally liberated tumor antigens to eliminate the cancer.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2013
  • Number of employees in Switzerland
    1-9